Pivotal Research reissued their buy rating on shares of Herbalife Ltd. (NYSE:HLF) in a research note issued to investors on Friday. The brokerage currently has a $90.00 price target on the stock.
Separately, Zacks Investment Research lowered Herbalife from a buy rating to a hold rating in a research report on Wednesday, October 5th. One equities research analyst has rated the stock with a sell rating, four have assigned a hold rating and one has assigned a buy rating to the company’s stock. The stock presently has an average rating of Hold and an average target price of $66.33.
Herbalife (NYSE:HLF) opened at 53.30 on Friday. The firm has a market capitalization of $4.96 billion, a price-to-earnings ratio of 18.71 and a beta of 1.72. The firm has a 50 day moving average price of $49.49 and a 200-day moving average price of $58.25. Herbalife has a 12 month low of $42.26 and a 12 month high of $72.22.
Herbalife (NYSE:HLF) last posted its quarterly earnings results on Tuesday, November 1st. The company reported $1.21 earnings per share for the quarter, beating the consensus estimate of $1.09 by $0.12. The firm had revenue of $1.12 billion for the quarter, compared to analyst estimates of $18.70 million. Herbalife had a return on equity of 1,018.52% and a net margin of 5.40%. Herbalife’s quarterly revenue was up 1.7% on a year-over-year basis. During the same period in the previous year, the firm earned $1.28 earnings per share. On average, equities analysts forecast that Herbalife will post $4.85 EPS for the current year.
In related news, major shareholder Carl C. Icahn acquired 1,832,402 shares of the stock in a transaction dated Thursday, November 3rd. The shares were acquired at an average price of $54.70 per share, with a total value of $100,232,389.40. The purchase was disclosed in a filing with the SEC, which is accessible through this hyperlink. Also, major shareholder Carl C. Icahn acquired 1,056,069 shares of the stock in a transaction dated Tuesday, November 8th. The shares were bought at an average cost of $55.05 per share, for a total transaction of $58,136,598.45. The disclosure for this purchase can be found here. Insiders own 4.91% of the company’s stock.
Hedge funds and other institutional investors have recently modified their holdings of the stock. Principal Financial Group Inc. raised its position in shares of Herbalife by 8.7% in the second quarter. Principal Financial Group Inc. now owns 16,599 shares of the company’s stock worth $972,000 after buying an additional 1,334 shares in the last quarter. Prudential Financial Inc. raised its position in shares of Herbalife by 13.9% in the second quarter. Prudential Financial Inc. now owns 4,921 shares of the company’s stock worth $288,000 after buying an additional 600 shares in the last quarter. Teacher Retirement System of Texas raised its position in shares of Herbalife by 15.3% in the second quarter. Teacher Retirement System of Texas now owns 9,845 shares of the company’s stock worth $576,000 after buying an additional 1,309 shares in the last quarter. Victory Capital Management Inc. raised its position in shares of Herbalife by 5.6% in the second quarter. Victory Capital Management Inc. now owns 17,361 shares of the company’s stock worth $1,016,000 after buying an additional 922 shares in the last quarter. Finally, UBS Asset Management Americas Inc. raised its position in shares of Herbalife by 18.7% in the second quarter. UBS Asset Management Americas Inc. now owns 82,827 shares of the company’s stock worth $4,848,000 after buying an additional 13,024 shares in the last quarter.
Herbalife Company Profile
Herbalife Ltd. is a global nutrition company. The Company develops and sells weight management, healthy meals and snacks, sports and fitness, energy and targeted nutritional products, as well as personal care products. The Company’s segments include North America; Mexico; South & Central America; Europe, Middle East, and Africa (EMEA); Asia Pacific, and China.